Does Tirzepatide work?

Read Off Label rates the evidence for Tirzepatide as Strong and the benefit magnitude as high, producing an overall grade of B (6.8/10). SURMOUNT-1: ~22.

Tirzepatide has a med risk profile in published human data. Legal status: Rx. This is not medical advice — see the disclaimer.

Rankings / Metabolic Health

Tirzepatide

Metabolic Health · GLP-1/GIP agonist (dual)

Also known as: Mounjaro ·Zepbound

Tier B

Reviewed by Read Off Label · Last reviewed Jun 7, 2026 · How we grade

glp-1gipprescription

6.8 / 10

Tier B

Ev 8 Bn 8 Sf 5

Bottom line

Read Off Label grades Tirzepatide as B (6.8/10) based on strong evidence, high benefit magnitude, and a med-risk safety profile.

SURMOUNT-1: ~22.

Typical use: Zepbound (obesity): titrate to 10-15 mg SC weekly; Mounjaro (T2DM) — Rx.

What this is

SURMOUNT-1: ~22.5% weight loss over 72 weeks at 15 mg — highest of any approved weight loss drug. SURMOUNT-5 (head-to-head 2025): tirzepatide -20.2% vs semaglutide -13.7% at 72 weeks. SURPASS-CVOT showed CV non-inferiority to dulaglutide. SURMOUNT-1 176-week extension (Heerspink 2026, Diabetes Obes Metab) confirmed sustained weight loss and renal-function preservation. Awaiting SURMOUNT-MMO for CV outcomes in obesity without diabetes.

Mechanism

Dual GIP/GLP-1 receptor agonist; GIP component enhances weight loss and glycemic effects beyond GLP-1 alone; mechanisms similar to semaglutide but more potent

Dose & route

Zepbound (obesity): titrate to 10-15 mg SC weekly; Mounjaro (T2DM)

Citations

Links go to the source. If a link is dead or you want something re-checked, let me know.

Common questions

Does Tirzepatide work?: Read Off Label rates the evidence for Tirzepatide as Strong and the benefit magnitude as high, producing an overall grade of B (6.8/10). SURMOUNT-1: ~22.
Is Tirzepatide safe?: Tirzepatide has a med risk profile in published human data. Legal status: Rx. This is not medical advice — see the disclaimer.
What is the typical dose for Tirzepatide?: Zepbound (obesity): titrate to 10-15 mg SC weekly; Mounjaro (T2DM)
How does Tirzepatide work?: Dual GIP/GLP-1 receptor agonist; GIP component enhances weight loss and glycemic effects beyond GLP-1 alone; mechanisms similar to semaglutide but more potent

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.